HomeFBIO • NASDAQ
Fortress Biotech Inc
add
$1.83
2.81%
Pre-market:(0.55%)-0.0100
$1.82
Closed: May 28, 6:11:18 AM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 13.14M | 0.84% |
Operating expense | 30.67M | 70.93% |
Net income | -10.58M | 31.35% |
Net profit margin | -80.55 | 31.92% |
Earnings per share | -0.48 | — |
EBITDA | -21.13M | 40.28% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.34M | 9.03% |
Total assets | 178.07M | 8.15% |
Total liabilities | 145.59M | -13.64% |
Total equity | 32.49M | — |
Shares outstanding | 29.55M | — |
Price to book | 2.37 | — |
Return on assets | -34.62% | — |
Return on capital | -61.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -10.58M | 31.35% |
Cash from operations | -19.56M | 22.94% |
Cash from investing | 1.17M | — |
Cash from financing | 52.14M | 87.16% |
Net change in cash | 33.74M | 1,265.05% |
Free cash flow | -13.43M | -13.03% |
Previous close
$1.78
Day range
$1.80 - $1.88
Year range
$1.33 - $2.89
Market cap
54.11M USD
Avg Volume
159.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Founded
2006
Headquarters
Website
Employees
101
